Novavax, the Covid-19 vaccine maker, has licensed the rights for a vaccine-enhancing component to Pfizer. Pfizer agreed to pay $30 million upfront, and could pay up to $500 million more if development ...
Hosted on MSN
GSK, CureVac to receive $740M as COVID vaccine patent dispute with Pfizer, BioNTech settled
CureVac (NASDAQ:CVAC) announced on Friday that the company and its partner, GSK (NYSE:GSK), are set to receive $740M and other payments, as Pfizer (NYSE:PFE) and BioNTech (NASDAQ:BNTX) have agreed to ...
The American Academy of Family Physicians (AAFP) split with federal health officials and recommended that all U.S. adults get an updated COVID-19 vaccine for the upcoming respiratory virus season. In ...
Jan 22 (Reuters) - Moderna (MRNA.O), opens new tab does not plan to invest in new late-stage vaccine trials because of growing opposition to immunizations from U.S. officials, CEO Stephane Bancel ...
Everything had been leading to the meeting early last year in Zanzibar, a tropical archipelago off the east coast of Africa. A hundred researchers, clinicians and other experts on HIV from across ...
Add Yahoo as a preferred source to see more of our stories on Google. Hall of Fame voter explains why he didn't vote for Bill Belichick, and it has nothing to do with Spygate JPMorgan, Bank of America ...
The Special Investigating Unit has announced a probe into four vaccine research procurement contracts following allegations of serious maladministration and improper conduct in the affairs of the ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results